| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A social science framework for the analysis of health technology regulation: the risks and benefits of innovative pharmaceuticals in a comparative context
|
Abraham, John
|
|
2002
|
4 |
3 |
p. 305-324
|
artikel
|
| 2 |
Book Reviews
|
|
|
2002
|
4 |
3 |
p. 341-343
|
artikel
|
| 3 |
From authority to authenticity: the changing governance of biotechnology
|
Brown, Nik
|
|
2002
|
4 |
3 |
p. 259-272
|
artikel
|
| 4 |
Good deaths, bad deaths: older people's assessments of the risks and benefits of morphine and terminal sedation in end-of-life care
|
Seymour, Jane E.
|
|
2002
|
4 |
3 |
p. 287-303
|
artikel
|
| 5 |
Making risk visible: the role of images in the assessment of (cancer) genetic risk
|
Prior, Lindsay
|
|
2002
|
4 |
3 |
p. 241-258
|
artikel
|
| 6 |
Narratives of risk: women at midlife, medical 'experts' and health technologies
|
Green, Eileen E.
|
|
2002
|
4 |
3 |
p. 273-286
|
artikel
|
| 7 |
Regulating human genetics: the changing politics of biotechnology governance in the European Union
|
Salter, Brian
|
|
2002
|
4 |
3 |
p. 325-340
|
artikel
|
| 8 |
Risk and Innovative Health Technologies: Calculation, Interpretation and Regulation
|
Webster, Andrew J.
|
|
2002
|
4 |
3 |
p. 221-226
|
artikel
|
| 9 |
Uncertain risk: genetic screening for susceptibility to haemochromatosis
|
Bharadwaj, Aditya
|
|
2002
|
4 |
3 |
p. 227-240
|
artikel
|
Tijdschrift beschrijving